Schedule 13G ownership disclosure

Onconova Therapeutics Inc

Security class unavailable · CUSIP: 68232V306

Event date: 2018-04-27

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
7,564,359
Percent of class
9.9900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000935836-18-000274
Form type
SC 13G
Filer
EcoR1 Capital, LLC
CIK
CIK 1587114
Filed
May 07, 2018
Reporting period
Apr 27, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub